MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$33,852K
(24.13%↑ Y/Y)
Other comprehensive
income/(loss) - foreign...
$8,026K
(688.42%↑ Y/Y)
Net loss
-$41,878K
(3.18%↑ Y/Y)
Net loss before
income tax
-$41,878K
(3.18%↑ Y/Y)
Interest income
$2,173K
(-28.54%↓ Y/Y)
Benefit from research
and development tax...
$1,850K
(12.19%↑ Y/Y)
Changes in the fair value
of warrants
$805K
(292.12%↑ Y/Y)
Loss from operations
-$40,107K
(15.32%↑ Y/Y)
Foreign currency
transaction (loss)/gain,...
-$6,344K
(-624.30%↓ Y/Y)
Revenue
$500K
Other income
$300K
Interest expense
$255K
(-81.39%↓ Y/Y)
General and
administrative
$23,008K
(-12.96%↓ Y/Y)
Research and development
$17,766K
(-15.12%↓ Y/Y)
Cost of revenue
$133K
Back
Back
Income Statement
source: myfinsight.com
Mereo BioPharma Group plc (MREO)
Mereo BioPharma Group plc (MREO)